Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 35 - The Real Truth

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise

Cytokinetics (NASDAQ:CYTK) executives said the commercial launch of MYKORZO is tracking ahead of internal expectations, while also highlighting positive physician feedback on the drug’s label, REMS program and recent clinical data in hypertrophic cardiomyopathy during a discussion hosted by RBC Capi

MarketBeat

Crexendo Says It’s on Track for $100M Revenue as AI and Acquisitions Fuel Growth

Crexendo (NASDAQ:CXDO) President and Chief Operating Officer Doug Gaylor told investors at an LD Micro presentation that the cloud communications company is on track for sharply higher revenue and is continuing to grow profitably while pursuing acquisitions among its software licensee base. Gaylor

MarketBeat

Cavco Industries Q4 Earnings Call Highlights

Cavco Industries (NASDAQ:CVCO) reported higher fourth-quarter revenue and profit compared with the prior year, while management said orders strengthened late in the period and backlogs improved heading into the new fiscal year. On the company’s fiscal fourth-quarter earnings call, President and CEO

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Global Ship Lease Q1 Earnings Call Highlights

Global Ship Lease (NYSE:GSL) executives said the container ship lessor entered 2026 with full charter coverage for the year, a strengthened balance sheet and more than $2 billion in contracted revenue, while warning that escalating geopolitical disruptions are reshaping global trade routes and vesse

MarketBeat

Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer

Bicara Therapeutics (NASDAQ:BCAX) said new data to be presented at the 2026 American Society of Clinical Oncology annual meeting support the clinical profile of ficerafusp alfa, also referred to by the company as Ficara, in first-line recurrent or metastatic HPV-negative head and neck cancer. On an

MarketBeat

Frontline Q1 Earnings Call Highlights

Frontline (NYSE:FRO) reported what Chief Executive Officer Lars Barstad called the company’s most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns. Speaking on the company’s first-quarter 2026 earn

MarketBeat

Flowers Foods Q1 Earnings Call Highlights

Flowers Foods (NYSE:FLO) said it delivered first-quarter bottom-line results ahead of expectations despite softer sales trends and continued pressure in the traditional bread category, as management pointed to brand investment, cost controls and balance sheet priorities as key themes for the rest of

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Imperial Petroleum Q1 Earnings Call Highlights

Imperial Petroleum (NASDAQ:IMPP) reported sharply higher first-quarter 2026 results, with management saying the company benefited from a larger fleet and a surge in tanker rates tied to geopolitical disruptions in the Middle East. Chief Executive Officer Harry Vafias said the quarter marked the com

MarketBeat

SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?

SpaceX filed its S-1 ahead of a historic June IPO. Here’s what investors should know about Starlink, valuation risks, and Elon Musk’s governance.

MarketBeat

CAVA Group’s Stock Looks Delicious After Strong Earnings

CAVA stock surged after the company posted strong Q1 earnings, raised guidance, and delivered impressive same-store sales growth despite valuation concerns

MarketBeat

CAE Q4 Earnings Call Highlights

CAE (NYSE:CAE) reported higher fourth-quarter and full-year revenue for fiscal 2026, but management said weaker civil aviation training conditions, disruption tied to the Middle East conflict and transformation-related costs weighed on profitability and will continue to affect the company’s near-ter

MarketBeat

ProSiebenSat.1 Media AGM Puts Entertainment Pivot, Cost Cuts in Spotlight

ProSiebenSat.1 Media (ETR:PSM) used its annual general meeting to outline a sharper focus on entertainment, tighter financial discipline and continued cost reductions following a year marked by weak advertising markets, portfolio disposals and a change in control after MFE became majority shareholde

MarketBeat

BJ's Wholesale Club Q1 Earnings Call Highlights

BJ's Wholesale Club (NYSE:BJ) reported a solid start to fiscal 2026, with management pointing to membership gains, higher fuel volumes, digital adoption and new club openings as key drivers of first-quarter performance. Chairman and Chief Executive Officer Bob Eddy said the retailer’s results were

MarketBeat

Booz Allen Hamilton Q4 Earnings Call Highlights

Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business. On t

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Lowe's Finds Support at $215 After Q1 Earnings Sell-Off

Lowe's stock is on track to rebound from its recent lows but it will take time for full price recovery. Catalysts include thawing housing markets.

MarketBeat

Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook

Deere stock fell after earnings despite a double beat as weakness in agriculture offset strong AI-driven construction demand tied to data center growth

MarketBeat

So-Young International Q1 Earnings Call Highlights

So-Young International (NASDAQ:SY) reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery. Total revenue rose 45.6

MarketBeat

Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half

e.l.f. Beauty is setting up for a rebound with the stock near long-term lows and growth catalysts ahead. Analysts forecast 75% upside.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential

Contineum Therapeutics (NASDAQ:CTNM) President and Chief Executive Officer Carmine Stengone said the company remains focused on advancing PIPE-791 in idiopathic pulmonary fibrosis, while recent exploratory pain data may point to additional clinical opportunities for the LPA1 receptor antagonist. Sp

MarketBeat

Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish

Biogen’s Alzheimer’s drug candidate showed promising tau-targeting results despite missing a primary endpoint, reinforcing long-term optimism for BIIB stock

MarketBeat

Intuit's Great SaaS Reset: Fired By AI

Intuit is aggressively shifting its corporate strategy toward artificial intelligence to streamline operations and unlock unprecedented margin expansion.

MarketBeat

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms

CorMedix (NASDAQ:CRMD) CEO Joe said the company is preparing for several potential commercial and regulatory catalysts across its infectious disease and dialysis-related portfolio, including a possible expansion of REZZAYO into fungal infection prophylaxis and continued work to sustain DefenCath uti

MarketBeat

Helical H2 Earnings Call Highlights

Helical (LON:HLCL) reported a year of operational progress and improved earnings as the London-focused developer advanced several major projects, completed the sale of 100 New Bridge Street and announced a larger return of capital to shareholders. Chief Executive Matthew Bonning-Snook said the comp

MarketBeat

Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first durability and progression-free survival data for the company’s highlighted cervical and head and neck canc

MarketBeat

Coinbase Global Says New Crypto Rules Could Unleash Its ‘Everything Exchange’

Coinbase Global (NASDAQ:COIN) executives said the company is preparing for a broader expansion of crypto trading, stablecoin payments, derivatives, tokenized assets and AI-driven commerce, with pending U.S. market structure legislation viewed as a potential catalyst. Speaking at JPMorgan’s TMC Conf

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.